Role of the pituitary-adrenal axis in granulocyte-colony stimulating factor-induced neuroprotection against hypoxia-ischemia in neonatal rats

Neurobiology of Disease

Volumn 47, Issue 1, 2012, Pages 29-37

  Charles, Mélissa S ^a   Ostrowski, Robert P ^a   Manaenko, Anatol ^a   Duris, Kamil ^a   Zhang, John H ^a   Tang, Jiping ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bax; Bcl 2; Caspase 3; Dexamethasone; G CSF; HPA axis; Hypoxia ischemia; Metyrapone

Indexed keywords

CASPASE; CORTICOSTERONE; CORTICOTROPIN; GRANULOCYTE COLONY STIMULATING FACTOR; METYRAPONE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG MECHANISM; HORMONE RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN EDEMA; CASPASE 3; CORTICOSTERONE; DEXAMETHASONE; DOWN-REGULATION; ENZYME INHIBITORS; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOXIA-ISCHEMIA, BRAIN; METYRAPONE; NEUROPROTECTIVE AGENTS; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84861227918     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.03.021     Document Type: Article

References (62)

1. Allen C., Kendall J.W. Maturation of the circadian rhythm of plasma corticosterone in the rat. Endocrinology 1967, 80(5):926-930. (May).
2. Baldi E., Bucherelli C. The inverted "u-shaped" dose-effect relationships in learning and memory: modulation of arousal and consolidation. Nonlinearity Biol. Toxicol. Med. 2005, 3(1):9-21. (Jan).
3. Betz A.L., Coester H.C. Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke 1990, 21(8):1199-1204. (Aug).
4. Butt T.K., Farooqui R., Khan M.A. Risk factors for hypoxic ischemic encephalopathy in children. J. Coll. Physicians Surg. Pak. 2008, 18(7):428-432. (Jul).
5. Chen W., Jadhav V., Tang J., Zhang J.H. HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol. Dis. 2008, 31(3):433-441. (Sep).
6. Chen W., Hartman R., Ayer R., Marcantonio S., Kamper J., Tang J., Zhang J.H. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J. Neurochem. 2009, 111(3):726-736. (Nov).
7. Chen W., Ma Q., Suzuki H., Hartman R., Tang J., Zhang J.H. Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model. Stroke 2011, 42(3):764-769. (Mar).
8. Davis P.G., Henderson-Smart D.J. Intravenous dexamethasone for extubation of newborn infants. Cochrane Database Syst. Rev. 2000, (2):CD000308. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD000308.
9. Dumas T.C., Gillette T., Ferguson D., Hamilton K., Sapolsky R.M. Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticity. J. Neurosci. 2010, 30(5):1712-1720. (Feb 3).
10. Ekert P., MacLusky N., Luo X.P., Lehotay D.C., Smith B., Post M., Tanswell A.K. Dexamethasone prevents apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy (HIE) by a reactive oxygen species-independent mechanism. Brain Res. 1997, 747(1):9-17. (Jan 30).
11. Fathali N., Lekic T., Zhang J.H., Tang J. Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats. Intensive Care Med. 2010, 36(9):1602-1608. (Sep).
12. Felszeghy K., Banisadr G., Rostène W., Nyakas C., Haour F. Dexamethasone down regulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 2004, 11(6):404-413.
13. Feng Y., Rhodes P.G., Bhatt A.J. Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. Neuroscience 2011, 179:223-232. (Apr 14).
14. Fishman R.A. Steroids in the treatment of brain edema. N. Engl. J. Med. 1982, 306(6):359-360. (Feb 11).
15. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 2005, 64(9):763-769. (Sep).
16. Giordano R., Picu A., Bonelli L., Balbo M., Berardelli R., Marinazzo E., Corneli G., Ghigo E., Arvat E. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin. Endocrinol. (Oxf) 2008, 68(6):935-941. (Jun).
17. Halliday H.L., Ehrenkranz R.A., Doyle L.W. Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst. Rev. 2009, 21(1):CD001146. (Jan).
18. Hattori H., Wasterlain C.G. Posthypoxic glucose supplement reduces hypoxic-ischemic brain damage in the neonatal rat. Ann. Neurol. 1990, 28(2):122-128.
19. Heiss J.D., Papavassiliou E., Merrill M.J., Nieman L., Knightly J.J., Walbridge S., Edwards N.A., Oldfield E.H. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Invest. 1996, 98(6):1400-1408. (Sep 15).
20. Hindmarsh K.W., Tan L., Sankaran K., Laxdal V.A. Diurnal rhythms of cortisol, ACTH, and beta-endorphin levels in neonates and adults. West. J. Med. 1989, 151(2):153-156. (Aug).
21. Ikeda T., Mishima K., Yoshikawa T., Iwasaki K., Fujiwara M., Xia Y.X., Ikenoue T. Dexamethasone prevents long-lasting learning impairment following neonatal hypoxic-ischemic brain insult in rats. Behav. Brain Res. 2002, 136(1):161-170. (Oct 17).
22. Ikeda T., Mishima K., Aoo N., Liu A.X., Egashira N., Iwasaki K., Fujiwara M., Ikenoue T. Dexamethasone prevents long-lasting learning impairment following a combination of lipopolysaccharide and hypoxia-ischemia in neonatal rats. Am. J. Obstet. Gynecol. 2005, 192(3):719-726. (Mar).
23. Konishi Y., Chui D.H., Hirose H., Kunishita T., Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 1993, 609(1-2):29-35. (Apr 23).
24. Krugers H.J., Kemper R.H., Korf J., Ter Horst G.J., Knollema S. Metyrapone reduces rat brain damage and seizures after hypoxia-ischemia: an effect independent of modulation of plasma corticosterone levels?. J. Cereb. Blood Flow Metab. 1998, 18(4):386-390.
25. Krugers H.J., Maslam S., Korf J., Joëls M., Holsboer F. The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia-induced loss of synaptic function in the rat hippocampus. Stroke 2000, 31(5):1162-1172.
26. Kuschinsky W., Gillardon F. Apoptosis and cerebral ischemia. Cerebrovasc. Dis. 2000, 10(3):165-169. (May-Jun).
27. Leal A.M., Carvalho J., Moreira A.C. Ontogenetic diurnal variation of adrenal responsiveness to ACTH and stress in rats. Horm. Res. 1999, 52(1):25-29.
28. Levin R., Levine S. Development of circadian periodicity in base and stress levels of corticosterone. Am. J. Physiol. 1975, 229(5):1397-1399. (Nov).
29. Levine S. The ontogeny of the hypothalamic-pituitary-adrenal axis: the influence of maternal factors. Ann. N. Y. Acad. Sci. 1994, 30(746):289-293.
30. MacPherson A., Dinkel K., Sapolsky R. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp. Neurol. 2005, 194(2):376-383. (Aug).
31. McIntosh L.J., Sapolsky R.M. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 1996, 17(3-4):873-882.
32. Mucha S., Zylińska K., Pisarek H., Komorowski J., Robak T., Korycka A., Stepień H. Pituitary-adrenocortical responses to the chronic administration of granulocyte colony-stimulating factor in rats. J. Neuroimmunol. 2000, 102(1):73-78. (Jan 3).
33. Murphy B.P., Inder T.E., Huppi P.S., Warfield S., Zientara G.P., Kikinis R., Jolesz F.A., Volpe J.J. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001, 107(2):217-221. (Feb).
34. Nakajima W., Ishida A., Lange M.S., Gabrielson K.L., Wilson M.A., Martin L.J., Blue M.E., Johnston M.V. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J. Neurosci. 2000, 20(21):7994-8004. (Nov 1).
35. Perlman J.M. Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics 2006, 117(3 Pt 2):S28-S33. (Mar).
36. Popa-Wagner A., Stöcker K., Balseanu A.T., Rogalewski A., Diederich K., Minnerup J., Margaritescu C., Schäbitz W.R. Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke 2010, 41(5):1027-1031. (May).
37. Pulera M.R., Adams L.M., Liu H., Santos D.G., Nishimura R.N., Yang F., Cole G.M., Wasterlain C.G. Apoptosis in a neonatal rat model of cerebral hypoxiaischemia. Stroke 1998, 29(12):2622-2630. (Dec).
38. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 1981, 9(2):131-141. (Feb).
39. Roy M., Sapolsky R.M. The exacerbation of hippocampalexcitotoxicity by glucocorticoids is not mediated by apoptosis. Neuroendocrinology 2003, 77(1):24-31.
40. Schäbitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Schölzke M.N., Sommer C., Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003, 34(3):745-751. (Mar).
41. Schäbitz W.R., Laage R., Vogt G., Koch W., Kollmar R., Schwab S., Schneider D., Hamann G.F., Rosenkranz M., Veltkamp R., Fiebach J.B., Hacke W., Grotta J.C., Fisher M., Schneider A. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 2010, 41(11):2545-2551. (Nov).
42. Schneider A., Krüger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schäbitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115(8):2083-2098. (Aug).
43. Solaroglu I., Tsubokawa T., Cahill J., Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143(4):965-974. (Dec 28).
44. Solaroglu I., Cahill J., Tsubokawa T., Beskonakli E., Zhang J.H. Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol. Res. 2009, 31(2):167-172. (Mar).
45. Sorrells S.F., Caso J.R., Munhoz C.D., Sapolsky R.M. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009, 64(1):33-39. (15).
46. Stein B.A., Sapolsky R.M. Chemical adrenalectomy reduces hippocampal damage induced by kainic acid. Brain Res. 1988, 473(1):175-180. (Nov 8).
47. Stein-Behrens B.A., Elliott E.M., Miller C.A., Schilling J.W., Newcombe R., Sapolsky R.M. Glucocorticoids exacerbate kainic acid-induced extracellular accumulation of excitatory amino acids in the rat hippocampus. J. Neurochem. 1992, 58(5):1730-1735.
48. Thébaud B., Lacaze-Masmonteil T., Watterberg K. Postnatal glucocorticoids in very preterm infants: "the good, the bad, and the ugly"?. Pediatrics 2001, 107(2):413-415. (Feb).
49. Tombaugh G.C., Sapolsky R.M. Corticosterone accelerates hypoxia- and cyanide-induced ATP loss in cultured hippocampalastrocytes. Brain Res. 1992, 588(1):154-158. (Aug 14).
50. Tuor U.I. Dexamethasone and the prevention of neonatal hypoxic-ischemic brain damage. Ann. N. Y. Acad. Sci. 1995, 765:179-195. (Sep 15).
51. Tuor U.I., Del Bigio M.R. Protection against hypoxic-ischemic damage with corticosterone and dexamethasone: inhibition of effect by a glucocorticoid antagonist RU38486. Brain Res. 1996, 743(1-2):258-262. (Dec 16).
52. Tuor U.I., Simone C.S., Arellano R., Tanswell K., Post M. Glucocorticoid prevention of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes. Brain Res. 1993, 604(1-2):165-172. (Feb 26).
53. Tuor U.I., Simone C.S., Barks J.D., Post M. Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats. Stroke 1993, 24(3):452-457. (Mar).
54. Vannucci R.C. Hypoxic-ischemic encephalopathy. Am. J. Perinatol. 2000, 17(3):113-120.
55. Vannucci R.C., Connor J.R., Mauger D.T., Palmer C., Smith M.B., Towfighi J., Vannucci S.J. Rat model of perinatal hypoxic-ischemic brain damage. J. Neurosci. Res. 1999, 55(2):158-163.
56. Vinson G.P. The adrenal cortex and life. Mol. Cell. Endocrinol. 2009, 300(1-2):2-6. (Mar 5).
57. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Ment. Retard. Dev. Disabil. Res. Rev. 2001, 7(1):56-64.
58. Wörle H., Versmold H. Hypoxic-ischemic encephalopathy. Clinical considerations. Padiatr. Padol. 1984, 19(4):355-364.
59. Yata K., Matchett G.A., Tsubokawa T., Tang J., Kanamaru K., Zhang J.H. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res. 2007, 1145:227-238. (May 11).
60. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., Tsai C.H. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 2004, 350(13):1304-1313. (Mar 25).
61. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000, 106(7):829-838. (Oct).
62. Zhou Y., Fathali N., Lekic T., Tang J., Zhang J.H. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats. Brain Res. 2009, 1270:131-139. (May 13).